{"url_path":"/sec/enta/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1177648/0001193125-26-220572-index.html","accession_number":"0001193125-26-220572","cik":"0001177648","ticker":"ENTA","issuer_name":"ENANTA PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1177648/0001193125-26-220572-index.html","primary_entity_key":"0001177648","primary_entity_name":"ENANTA PHARMACEUTICALS INC"},"word_count":284,"has_tables":true,"body_markdown":"ITEM 6. EXHIBITS\n\n \n\n \n\n \n\n \n\n \n\nIncorporated by Reference\n\n \n\n \n\nExhibit\n\nNumber\n\n \n\nExhibit Description\n\n \n\nForm\n\n \n\nDate\n\n \n\nExhibit\n\nNumber\n\n \n\nFile Number\n\n \n\nFiled\n\nHerewith\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n3.1\n\n \n\n[Restated Certificate of Incorporation of Enanta Pharmaceuticals, Inc.](https://www.sec.gov/Archives/edgar/data/1177648/000119312513132679/d511662dex31.htm)\n\n \n\n8-K\n\n \n\n03/28/2013\n\n \n\n3.1\n\n \n\n001-35839\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n3.2\n\n \n\n[Amended and Restated Bylaws of Enanta Pharmaceuticals, Inc. (as amended and restated in August 2015)](https://www.sec.gov/Archives/edgar/data/1177648/000119312515294582/d95810dex32.htm)\n\n \n\n8-K\n\n \n\n08/18/2015\n\n \n\n3.2\n\n \n\n001-35839\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n10.1\n\n \n\n[2019 Equity Incentive Plan (as amended March 2026)](https://www.sec.gov/Archives/edgar/data/1177648/000119312526104109/enta-ex10_1.htm)\n\n \n\n8-K\n\n \n\n \n\n03/12/2026\n\n \n\n \n\n10.1\n\n \n\n \n\n001-35839\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n31.1\n\n \n\n[Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934.](enta-ex31_1.htm)\n\n \n\n—\n\n \n\n—\n\n \n\n—\n\n \n\n—\n\n \n\nX\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n31.2\n\n \n\n[Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934.](enta-ex31_2.htm)\n\n \n\n—\n\n \n\n—\n\n \n\n—\n\n \n\n—\n\n \n\nX\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n32.1\n\n \n\n[Certification of the Principal Executive Officer and](enta-ex32_1.htm)Principal Financial Officer[pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](enta-ex32_1.htm)\n\n \n\n—\n\n \n\n—\n\n \n\n—\n\n \n\n—\n\n \n\nX\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n101.INS\n\n \n\nXBRL Instance Document - The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document\n\n \n\n \n\n \n\n \n\n \n\nX\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n101.SCH\n\n \n\nInline XBRL Taxonomy Extension Schema with embedded Linkbases document\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nX\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n104\n\n \n\n \n\n \n\n \n\n \n\n \n\nCover Page Interactive Data File (formatted as Inline XBRL with applicable Taxonomy Extension information contained in Exhibit 101).\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nX\n\n \n\n29\n\nENANTA PHARMACEUTICALS, INC.\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\nENANTA PHARMACEUTICALS, INC.\n\n \n\n \n\n \n\nDate: May 13, 2026\n\n \n\n \n\n/s/ Jay R. Luly, Ph.D.\n\n \n\n \n\nJay R. Luly, Ph.D.\n\nPresident and Chief Executive Officer\n\n(Principal Executive Officer)\n\n \n\nDate: May 13, 2026\n\n \n\n \n\n/s/ Harry R. Trout III\n\n \n\n \n\nHarry R. Trout III\n\nVice President, Finance\n\n(Principal Financial Officer)\n\n \n\n \n\n30"}